Lung Cancer Latest News
Older News Vote! Pharmacogenetics of EGFR in lung cancer: perspectives and clinical applications MedWorm/BreastCancer (Today) - Pharmacogenomics , May 2012, Vol. 13, No. 7, Pages 789-802. (Source: Future Medicine: Pharmacogenomics)... Vote! AATS Focus on Thoracic Surgery: Lung Cancer MedWorm/BreastCancer (Today) - November 16–17, 2012 Boston Marriott Copley Place (Source: The Journal of Thoracic and Cardiovascular Surgery)... Vote! Neutrophil Elastase as a Target in Lung Cancer MedWorm/BreastCancer (Today) - (Source: Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents))MedWorm Message: Please... Vote! Chronic modulation of AMP-Kinase, Akt and
mTOR pathways by ionizing radiation in human
lung cancer xenografts MedWorm/BreastCancer (Today) - Conclusion: IR inhibits epithelial cancer tumour growth and results in sustained expression and activationof ATM-Chk2,... Vote! Anticoagulant and Fibrinolytic Drugs Possible Agents in Treatment of Lung Cancer? MedWorm/BreastCancer (Today) - (Source: Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents))MedWorm Message: Please... Vote! Trigoxyphins H and I: Two new daphnane diterpenoids from Trigonostemon xyphophylloides. MedWorm/BreastCancer (Today) - Authors: Yang B, Chen GY, Song XP, Yang LQ, Han CR, Wu XY, Li XM,... Vote! Phase 1 dose‐escalation trial evaluating the combination of the selective MET (mesenchymal‐epithelial transition factor) inhibitor tivantinib (ARQ 197) plus erlotinib MedWorm/BackPain (Today) - CONCLUSIONS:Tivantinib plus erlotinib was well tolerated with encouraging clinical activity, especially in patients with nonsmall... Vote! Varian Medical Systems to Showcase Radiosurgery Technology for Non-invasive Treatment of Early Stage Inoperable Lung Cancer MedWorm/EarlyIntervention (Today) - SAN FRANCISCO, May 17, 2012 (HSMN NewsFeed) -- Varian Medical Systems (VAR) will showcase radiosurgery... Vote! Local cancer survival rates fall short - Hamilton Spectator Google/BreastCancer (Yesterday) - CBC.caLocal cancer survival rates fall shortHamilton SpectatorBreast and lung cancer survival rates in Hamilton and... Vote! RASSF1C modulates the expression of a stem cell renewal gene, PIWIL1 MedWorm/BreastCancer (Yesterday) - Conclusions: Taken together, our findings provide significant data to propose a model for investigating the... Vote! The value of pleural lavage cytology examined during surgery for primary lung cancer [THORACIC] MedWorm/BreastCancer (Yesterday) - CONCLUSIONS Examining PLC in clinical practice is useful for detecting occult pleural dissemination before the... Vote! Effects of low-dose human atrial natriuretic peptide for preventing post-operative cardiopulmonary complications in elderly patients undergoing pulmonary resection for lung cancer [THORACIC] MedWorm/BreastCancer (Yesterday) - CONCLUSIONS Continuous infusion of low-dose hANP during lung cancer surgery had a prophylactic effect on... Vote! The importance of intraoperative fluid balance for the prevention of postoperative acute exacerbation of idiopathic pulmonary fibrosis after pulmonary resection for primary lung cancer [THORACIC] MedWorm/BreastCancer (Yesterday) - CONCLUSIONS To prevent PAE of IPF, intraoperative management that minimizes intravenous fluid administration is essential.... Vote! Diagnostic and Prognostic Impact of Serum Soluble UL16‐Binding Protein 2 in Lung Cancer Patients MedWorm/BreastCancer (Yesterday) - In conclusion, ULBP2 is the most significant NKG2DL for lung cancer, and sULBP2 is useful... Vote! Quality of life aids lung cancer prognosis MedWorm/BreastCancer (Yesterday) - Self-reported quality of life at the time of lung cancer diagnosis has a significant impact... Vote! In Clinical Trials, Breath Test for Lung Cancer Shows Promise for Earlier Detection MedWorm/BreastCancer (Yesterday) - Pathologists may do fewer lung biopsies should non-invasive breath testing technology make it into clinical... Vote! Ectopic Expression of TIM-3 in Lung Cancers: A Potential Independent Prognostic Factor for Patients With NSCLC. MedWorm/BreastCancer (Yesterday) - Authors: Zhuang X, Zhang X, Xia X, Zhang C, Liang X, Gao L, Zhang X,... Vote! Tissue-Sparing Application of the Newly Proposed IASLC/ATS/ERS Classification of Adenocarcinoma of the Lung Shows Practical Diagnostic and Prognostic Impact. MedWorm/BreastCancer (Yesterday) - Authors: Sterlacci W, Savic S, Schmid T, Oberaigner W, Auberger J, Fiegl M, Tzankov A...